Operating Lease, Right-of-Use Asset in USD of NKGen Biotech, Inc. from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NKGen Biotech, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2022 to Q4 2024.
  • NKGen Biotech, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $379K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

NKGen Biotech, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $379K +$379K 31 Dec 2024 10-K 08 Oct 2025
Q3 2024 $415K +$326K +366% 30 Sep 2024 10-Q 04 Mar 2025
Q2 2024 $450K 30 Jun 2024 10-Q 12 Sep 2024
Q1 2024 $482K 31 Mar 2024 10-Q 20 May 2024
Q4 2023 $0 -$362K -100% 31 Dec 2023 10-K 08 Oct 2025
Q3 2023 $89K 30 Sep 2023 10-Q 14 Nov 2023
Q4 2022 $362K 31 Dec 2022 10-K 16 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.